Date
- 2026 (1)
- 2025 (38)
- 2024 (86)
- 2023 (73)
- 2022 (59)
- 2021 (124)
- 2020 (107)
- 2019 (98)
- 2018 (95)
- 2017 (73)
- 2016 (12)
- 2015 (22)
- 2014 (19)
- 2013 (9)
- 2012 (8)
- 2011 (14)
- 2010 (27)
- 2009 (13)
- 2008 (5)
- 2007 (11)
- 2006 (8)
- 2005 (4)
- 2004 (8)
- 2003 (3)
- 2002 (10)
- 2001 (6)
- 2000 (20)
- 1999 (9)
- 1998 (12)
- 1997 (16)
- 1996 (8)
- 1995 (3)
- 1994 (31)
- 1993 (17)
- 1992 (5)
- 1991 (86)
Sponsor content
1140 result(s) found, displaying 491 to 500
-
Cancellation or suspensionRegulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 19/06/2020
-
Cancellation or suspensionRegulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 19/06/2020
-
Cancellation or suspensionRegulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 18/06/2020
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DBL BORTEZOMIB 2.5 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DBL BORTEZOMIB 3.5 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DBL BORTEZOMIB 3.0 mg powder for injection vial.
-
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd